\n

\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

英文名称\xa0 Anti-IGFBP3\xa0

中文名称\xa0 胰岛素样生长因子结合蛋白3抗体\xa0

别\xa0\xa0\xa0 名\xa0 IGF BP3; IGF-BP3; Acid stable subunit of the 140 K IGF complex; Binding protein 29; Binding protein 53; BP 53; BP53; Growth hormone dependent binding protein; IBP 3; IBP3; IGF binding protein 3; IGFBP 3;IGFBP-3; Insulin Like Growth Factor Binding Protein 3.\xa0

浓\xa0\xa0\xa0 度\xa0 1mg/1ml\xa0

规 格\xa0 0.1ml/100μg\xa0 0.2ml/200μg\xa0\xa0\xa0\xa0\xa0

抗体来源\xa0 Rabbit\xa0\xa0

克隆类型\xa0 polyclonal\xa0

交叉反应\xa0 Human, Mouse, Rat

产品类型\xa0 一抗\xa0\xa0\xa0\xa0

研究领域\xa0 肿瘤 细胞生物 免疫学 生长因子和激素 转录调节因子 糖尿病\xa0\xa0 \t\t\t

蛋白分子量\xa0 predicted molecular weight: 30-35kDa\xa0

性\xa0\xa0\xa0 状\xa0 Lyophilized or Liquid\xa0

免 疫 原\xa0 KLH conjugated synthetic peptide derived from human IGFBP3 C-terminus\xa0

亚\xa0\xa0\xa0 型\xa0 IgG\xa0

纯化方法\xa0 affinity purified by Protein A\xa0

储 存 液\xa0 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide\xa0

产品应用\xa0\xa0 WB=1:100-500\xa0 ELISA=1:500-1000\xa0 IP=1:20-100\xa0 IHC-P=1:100-500\xa0 IHC-F=1:100-500\xa0 IF=1:100-500\xa0 \t\t\t \t\t\t抗体的生物素化标记： \t\t\t（一）基本原理 \t\t\t本法可使抗体或其它蛋白质的e-氨基通过手臂与酰化的生物素共价结合。其后,生物素化的分子可应用酶标-亲和素或荧光染料-链霉亲和素复合物来检测。 \t\t\t（二）实验前准备 \t\t\t1.仪器设备 \t\t\t微量移液器，铝铂，透析袋(MWCO8000)，电磁搅拌器，分子筛柱。 \t\t\t2.试剂 \t\t\tNHSB:N-羟基琥珀酰亚胺生物素，0.1 mol/L碳酸氢钠缓冲液，双蒸水(注意去除游离氨基),用以配制碳酸氢钠缓冲液或硼酸缓冲液DMS0，10g/L牛血清白蛋白(W/W)PBS液等 \t\t\t（三）结果判定 \t\t\t与酶-或荧光染料-结合的亲和素、链霉亲和素或中和亲和素( neutravidin),通过标准方法（Westerblotting或免疫荧光染色法）测定交联率 \t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t solute carrier family 1\xa0\xa0溶质携带物家族-1(抗原) SLC6A4 (solute carrier family 6)\xa0\xa0钾依赖钠钙交换蛋白6(抗原) Survivin\xa0\xa0细胞凋亡抑制因子的一种（抗原） BIYT5/Survivin variant\xa0\xa0细胞凋亡抑制因子4（抗原） SSA/RO (ribonucleoprotein complex,RNP)\xa0\xa0核糖核蛋白抗原SSA(抗原) SSB/La(Sjogren syndrome type B antigen)(抗原)\xa0\xa0抗干燥症SSB/La蛋白抗体 Smad2(Mothers against decapentaplegic homolog 2)\xa0\xa0Smad 2/3(抗原) SPAG5/map126 (sperm associated antigen 5）\xa0\xa0抗精子相关抗原5(抗原) SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原) SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原) SYVN1(synovial apoptosis inhibitor 1)\xa0\xa0滑膜细胞凋亡抑制物1（抗体） SYK (Spleen tyrosine kinase)\xa0\xa0非受体型酪氨酸激酶(抗原) \t\t\t \t\t\t\xa0

\t\t\t\t\t\t\t\t\t\t\t\t\t英文名称\xa0 Anti-IGFBP3\xa0\t\t\t\t\t\t\t中文名称\xa0 胰岛素样生长因子结合蛋白3抗体\xa0\t\t\t\t\t\t\t别\xa0\xa0\xa0 名\xa0 IGF BP3; IGF-BP3; Acid stable subunit of the 140 K IGF complex; Binding protein 29; Binding protein 53; BP 53; BP53; Growth hormone dependent binding protein; IBP 3; IBP3; IGF binding protein 3; IGFBP 3;IGFBP-3; Insulin Like Growth Factor Binding Protein 3.\xa0\t\t\t\t\t\t\t浓\xa0\xa0\xa0 度\xa0 1mg/1ml\xa0\t\t\t\t\t\t\t规 格\xa0 0.1ml/100μg\xa0 0.2ml/200μg\xa0\xa0\xa0\xa0\xa0\t\t\t\t\t\t\t抗体来源\xa0 Rabbit\xa0\xa0\t\t\t\t\t\t\t克隆类型\xa0 polyclonal\xa0\t\t\t\t\t\t\t交叉反应\xa0 Human, Mouse, Rat\t\t\t\t\t\t\t产品类型\xa0 一抗\xa0\xa0\xa0\xa0\t\t\t\t\t\t\t研究领域\xa0 肿瘤 细胞生物 免疫学 生长因子和激素 转录调节因子 糖尿病\xa0\xa0
\t\t\t\t\t\t\t\t\t\t蛋白分子量\xa0 predicted molecular weight: 30-35kDa\xa0\t\t\t\t\t\t\t性\xa0\xa0\xa0 状\xa0 Lyophilized or Liquid\xa0\t\t\t\t\t\t\t免 疫 原\xa0 KLH conjugated synthetic peptide derived from human IGFBP3 C-terminus\xa0\t\t\t\t\t\t\t亚\xa0\xa0\xa0 型\xa0 IgG\xa0\t\t\t\t\t\t\t纯化方法\xa0 affinity purified by Protein A\xa0\t\t\t\t\t\t\t储 存 液\xa0 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide\xa0\t\t\t\t\t\t\t产品应用\xa0\xa0 WB=1:100-500\xa0 ELISA=1:500-1000\xa0 IP=1:20-100\xa0 IHC-P=1:100-500\xa0 IHC-F=1:100-500\xa0 IF=1:100-500\xa0
\t\t\t
\t\t\t抗体的生物素化标记：
\t\t\t（一）基本原理
\t\t\t本法可使抗体或其它蛋白质的e-氨基通过手臂与酰化的生物素共价结合。其后,生物素化的分子可应用酶标-亲和素或荧光染料-链霉亲和素复合物来检测。
\t\t\t（二）实验前准备
\t\t\t1.仪器设备
\t\t\t微量移液器，铝铂，透析袋(MWCO8000)，电磁搅拌器，分子筛柱。
\t\t\t2.试剂
\t\t\tNHSB:N-羟基琥珀酰亚胺生物素，0.1 mol/L碳酸氢钠缓冲液，双蒸水(注意去除游离氨基),用以配制碳酸氢钠缓冲液或硼酸缓冲液DMS0，10g/L牛血清白蛋白(W/W)PBS液等
\t\t\t（三）结果判定
\t\t\t与酶-或荧光染料-结合的亲和素、链霉亲和素或中和亲和素( neutravidin),通过标准方法（Westerblotting或免疫荧光染色法）测定交联率
\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

solute carrier family 1\xa0\xa0溶质携带物家族-1(抗原)

SLC6A4 (solute carrier family 6)\xa0\xa0钾依赖钠钙交换蛋白6(抗原)

Survivin\xa0\xa0细胞凋亡抑制因子的一种（抗原）

BIYT5/Survivin variant\xa0\xa0细胞凋亡抑制因子4（抗原）

SSA/RO (ribonucleoprotein complex,RNP)\xa0\xa0核糖核蛋白抗原SSA(抗原)

SSB/La(Sjogren syndrome type B antigen)(抗原)\xa0\xa0抗干燥症SSB/La蛋白抗体

Smad2(Mothers against decapentaplegic homolog 2)\xa0\xa0Smad 2/3(抗原)

SPAG5/map126 (sperm associated antigen 5）\xa0\xa0抗精子相关抗原5(抗原)

SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)

SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)

SYVN1(synovial apoptosis inhibitor 1)\xa0\xa0滑膜细胞凋亡抑制物1（抗体）

SYK (Spleen tyrosine kinase)\xa0\xa0非受体型酪氨酸激酶(抗原)

\t\t\t
\t\t\t\xa0\t\t\t\t\t\t\t\t英文名称\xa0 Anti-IGFBP3\xa0\t\t\t\t\t英文名称\xa0 Anti-IGFBP3\xa0英文名称\xa0 Anti-IGFBP3\xa0英文名称\xa0 Anti-IGFBP3\xa0英文名称\xa0 Anti-IGFBP3\xa0\t\t\t\t\t\t\t中文名称\xa0 胰岛素样生长因子结合蛋白3抗体\xa0\t\t\t\t\t中文名称\xa0 胰岛素样生长因子结合蛋白3抗体\xa0中文名称\xa0 胰岛素样生长因子结合蛋白3抗体\xa0中文名称\xa0 胰岛素样生长因子结合蛋白3抗体\xa0中文名称\xa0 胰岛素样生长因子结合蛋白3抗体\xa0\t\t\t\t\t\t\t别\xa0\xa0\xa0 名\xa0 IGF BP3; IGF-BP3; Acid stable subunit of the 140 K IGF complex; Binding protein 29; Binding protein 53; BP 53; BP53; Growth hormone dependent binding protein; IBP 3; IBP3; IGF binding protein 3; IGFBP 3;IGFBP-3; Insulin Like Growth Factor Binding Protein 3.\xa0\t\t\t\t\t别\xa0\xa0\xa0 名\xa0 IGF BP3; IGF-BP3; Acid stable subunit of the 140 K IGF complex; Binding protein 29; Binding protein 53; BP 53; BP53; Growth hormone dependent binding protein; IBP 3; IBP3; IGF binding protein 3; IGFBP 3;IGFBP-3; Insulin Like Growth Factor Binding Protein 3.\xa0别\xa0\xa0\xa0 名\xa0 IGF BP3; IGF-BP3; Acid stable subunit of the 140 K IGF complex; Binding protein 29; Binding protein 53; BP 53; BP53; Growth hormone dependent binding protein; IBP 3; IBP3; IGF binding protein 3; IGFBP 3;IGFBP-3; Insulin Like Growth Factor Binding Protein 3.\xa0别\xa0\xa0\xa0 名\xa0 IGF BP3; IGF-BP3; Acid stable subunit of the 140 K IGF complex; Binding protein 29; Binding protein 53; BP 53; BP53; Growth hormone dependent binding protein; IBP 3; IBP3; IGF binding protein 3; IGFBP 3;IGFBP-3; Insulin Like Growth Factor Binding Protein 3.\xa0别\xa0\xa0\xa0 名\xa0 IGF BP3; IGF-BP3; Acid stable subunit of the 140 K IGF complex; Binding protein 29; Binding protein 53; BP 53; BP53; Growth hormone dependent binding protein; IBP 3; IBP3; IGF binding protein 3; IGFBP 3;IGFBP-3; Insulin Like Growth Factor Binding Protein 3.\xa0\t\t\t\t\t\t\t浓\xa0\xa0\xa0 度\xa0 1mg/1ml\xa0\t\t\t\t\t浓\xa0\xa0\xa0 度\xa0 1mg/1ml\xa0浓\xa0\xa0\xa0 度\xa0 1mg/1ml\xa0浓\xa0\xa0\xa0 度\xa0 1mg/1ml\xa0浓\xa0\xa0\xa0 度\xa0 1mg/1ml\xa0\t\t\t\t\t\t\t规 格\xa0 0.1ml/100μg\xa0 0.2ml/200μg\xa0\xa0\xa0\xa0\xa0\t\t\t\t\t规 格\xa0 0.1ml/100μg\xa0 0.2ml/200μg\xa0\xa0\xa0\xa0\xa0规 格\xa0 0.1ml/100μg\xa0 0.2ml/200μg\xa0\xa0\xa0\xa0\xa0规 格\xa0 0.1ml/100μg\xa0 0.2ml/200μg\xa0\xa0\xa0\xa0\xa0规 格\xa0 0.1ml/100μg\xa0 0.2ml/200μg\xa0\xa0\xa0\xa0\xa0\t\t\t\t\t\t\t抗体来源\xa0 Rabbit\xa0\xa0\t\t\t\t\t抗体来源\xa0 Rabbit\xa0\xa0抗体来源\xa0 Rabbit\xa0\xa0抗体来源\xa0 Rabbit\xa0\xa0抗体来源\xa0 Rabbit\xa0\xa0\t\t\t\t\t\t\t克隆类型\xa0 polyclonal\xa0\t\t\t\t\t克隆类型\xa0 polyclonal\xa0克隆类型\xa0 polyclonal\xa0克隆类型\xa0 polyclonal\xa0克隆类型\xa0 polyclonal\xa0\t\t\t\t\t\t\t交叉反应\xa0 Human, Mouse, Rat\t\t\t\t\t交叉反应\xa0 Human, Mouse, Rat交叉反应\xa0 Human, Mouse, Rat交叉反应\xa0 Human, Mouse, Rat交叉反应\xa0 Human, Mouse, Rat\t\t\t\t\t\t\t产品类型\xa0 一抗\xa0\xa0\xa0\xa0\t\t\t\t\t产品类型\xa0 一抗\xa0\xa0\xa0\xa0产品类型\xa0 一抗\xa0\xa0\xa0\xa0产品类型\xa0 一抗\xa0\xa0\xa0\xa0产品类型\xa0 一抗\xa0\xa0\xa0\xa0\t\t\t\t\t\t\t研究领域\xa0 肿瘤 细胞生物 免疫学 生长因子和激素 转录调节因子 糖尿病\xa0\xa0
\t\t\t\t\t\t\t\t研究领域\xa0 肿瘤 细胞生物 免疫学 生长因子和激素 转录调节因子 糖尿病\xa0\xa0
\t\t\t研究领域\xa0 肿瘤 细胞生物 免疫学 生长因子和激素 转录调节因子 糖尿病\xa0\xa0
\t\t\t研究领域\xa0 肿瘤 细胞生物 免疫学 生长因子和激素 转录调节因子 糖尿病\xa0\xa0
\t\t\t研究领域\xa0 肿瘤 细胞生物 免疫学 生长因子和激素 转录调节因子 糖尿病\xa0\xa0
\t\t\t\t\t\t\t\t\t\t蛋白分子量\xa0 predicted molecular weight: 30-35kDa\xa0\t\t\t\t\t蛋白分子量\xa0 predicted molecular weight: 30-35kDa\xa0蛋白分子量\xa0 predicted molecular weight: 30-35kDa\xa0蛋白分子量\xa0 predicted molecular weight: 30-35kDa\xa0蛋白分子量\xa0 predicted molecular weight: 30-35kDa\xa0\t\t\t\t\t\t\t性\xa0\xa0\xa0 状\xa0 Lyophilized or Liquid\xa0\t\t\t\t\t性\xa0\xa0\xa0 状\xa0 Lyophilized or Liquid\xa0性\xa0\xa0\xa0 状\xa0 Lyophilized or Liquid\xa0性\xa0\xa0\xa0 状\xa0 Lyophilized or Liquid\xa0性\xa0\xa0\xa0 状\xa0 Lyophilized or Liquid\xa0\t\t\t\t\t\t\t免 疫 原\xa0 KLH conjugated synthetic peptide derived from human IGFBP3 C-terminus\xa0\t\t\t\t\t免 疫 原\xa0 KLH conjugated synthetic peptide derived from human IGFBP3 C-terminus\xa0免 疫 原\xa0 KLH conjugated synthetic peptide derived from human IGFBP3 C-terminus\xa0免 疫 原\xa0 KLH conjugated synthetic peptide derived from human IGFBP3 C-terminus\xa0免 疫 原\xa0 KLH conjugated synthetic peptide derived from human IGFBP3 C-terminus\xa0\t\t\t\t\t\t\t亚\xa0\xa0\xa0 型\xa0 IgG\xa0\t\t\t\t\t亚\xa0\xa0\xa0 型\xa0 IgG\xa0亚\xa0\xa0\xa0 型\xa0 IgG\xa0亚\xa0\xa0\xa0 型\xa0 IgG\xa0亚\xa0\xa0\xa0 型\xa0 IgG\xa0\t\t\t\t\t\t\t纯化方法\xa0 affinity purified by Protein A\xa0\t\t\t\t\t纯化方法\xa0 affinity purified by Protein A\xa0纯化方法\xa0 affinity purified by Protein A\xa0纯化方法\xa0 affinity purified by Protein A\xa0纯化方法\xa0 affinity purified by Protein A\xa0\t\t\t\t\t\t\t储 存 液\xa0 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide\xa0\t\t\t\t\t储 存 液\xa0 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide\xa0储 存 液\xa0 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide\xa0储 存 液\xa0 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide\xa0储 存 液\xa0 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide\xa0\t\t\t\t\t\t\t产品应用\xa0\xa0 WB=1:100-500\xa0 ELISA=1:500-1000\xa0 IP=1:20-100\xa0 IHC-P=1:100-500\xa0 IHC-F=1:100-500\xa0 IF=1:100-500\xa0
\t\t\t
\t\t\t抗体的生物素化标记：
\t\t\t（一）基本原理
\t\t\t本法可使抗体或其它蛋白质的e-氨基通过手臂与酰化的生物素共价结合。其后,生物素化的分子可应用酶标-亲和素或荧光染料-链霉亲和素复合物来检测。
\t\t\t（二）实验前准备
\t\t\t1.仪器设备
\t\t\t微量移液器，铝铂，透析袋(MWCO8000)，电磁搅拌器，分子筛柱。
\t\t\t2.试剂
\t\t\tNHSB:N-羟基琥珀酰亚胺生物素，0.1 mol/L碳酸氢钠缓冲液，双蒸水(注意去除游离氨基),用以配制碳酸氢钠缓冲液或硼酸缓冲液DMS0，10g/L牛血清白蛋白(W/W)PBS液等
\t\t\t（三）结果判定
\t\t\t与酶-或荧光染料-结合的亲和素、链霉亲和素或中和亲和素( neutravidin),通过标准方法（Westerblotting或免疫荧光染色法）测定交联率
\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

solute carrier family 1\xa0\xa0溶质携带物家族-1(抗原)

SLC6A4 (solute carrier family 6)\xa0\xa0钾依赖钠钙交换蛋白6(抗原)

Survivin\xa0\xa0细胞凋亡抑制因子的一种（抗原）

BIYT5/Survivin variant\xa0\xa0细胞凋亡抑制因子4（抗原）

SSA/RO (ribonucleoprotein complex,RNP)\xa0\xa0核糖核蛋白抗原SSA(抗原)

SSB/La(Sjogren syndrome type B antigen)(抗原)\xa0\xa0抗干燥症SSB/La蛋白抗体

Smad2(Mothers against decapentaplegic homolog 2)\xa0\xa0Smad 2/3(抗原)

SPAG5/map126 (sperm associated antigen 5）\xa0\xa0抗精子相关抗原5(抗原)

SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)

SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)

SYVN1(synovial apoptosis inhibitor 1)\xa0\xa0滑膜细胞凋亡抑制物1（抗体）

SYK (Spleen tyrosine kinase)\xa0\xa0非受体型酪氨酸激酶(抗原)

\t\t\t
\t\t\t\xa0\t\t\t\t\t产品应用\xa0\xa0 WB=1:100-500\xa0 ELISA=1:500-1000\xa0 IP=1:20-100\xa0 IHC-P=1:100-500\xa0 IHC-F=1:100-500\xa0 IF=1:100-500\xa0
\t\t\t
\t\t\t抗体的生物素化标记：
\t\t\t（一）基本原理
\t\t\t本法可使抗体或其它蛋白质的e-氨基通过手臂与酰化的生物素共价结合。其后,生物素化的分子可应用酶标-亲和素或荧光染料-链霉亲和素复合物来检测。
\t\t\t（二）实验前准备
\t\t\t1.仪器设备
\t\t\t微量移液器，铝铂，透析袋(MWCO8000)，电磁搅拌器，分子筛柱。
\t\t\t2.试剂
\t\t\tNHSB:N-羟基琥珀酰亚胺生物素，0.1 mol/L碳酸氢钠缓冲液，双蒸水(注意去除游离氨基),用以配制碳酸氢钠缓冲液或硼酸缓冲液DMS0，10g/L牛血清白蛋白(W/W)PBS液等
\t\t\t（三）结果判定
\t\t\t与酶-或荧光染料-结合的亲和素、链霉亲和素或中和亲和素( neutravidin),通过标准方法（Westerblotting或免疫荧光染色法）测定交联率
\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

solute carrier family 1\xa0\xa0溶质携带物家族-1(抗原)

SLC6A4 (solute carrier family 6)\xa0\xa0钾依赖钠钙交换蛋白6(抗原)

Survivin\xa0\xa0细胞凋亡抑制因子的一种（抗原）

BIYT5/Survivin variant\xa0\xa0细胞凋亡抑制因子4（抗原）

SSA/RO (ribonucleoprotein complex,RNP)\xa0\xa0核糖核蛋白抗原SSA(抗原)

SSB/La(Sjogren syndrome type B antigen)(抗原)\xa0\xa0抗干燥症SSB/La蛋白抗体

Smad2(Mothers against decapentaplegic homolog 2)\xa0\xa0Smad 2/3(抗原)

SPAG5/map126 (sperm associated antigen 5）\xa0\xa0抗精子相关抗原5(抗原)

SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)

SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)

SYVN1(synovial apoptosis inhibitor 1)\xa0\xa0滑膜细胞凋亡抑制物1（抗体）

SYK (Spleen tyrosine kinase)\xa0\xa0非受体型酪氨酸激酶(抗原)

\t\t\t
\t\t\t\xa0产品应用\xa0\xa0 WB=1:100-500\xa0 ELISA=1:500-1000\xa0 IP=1:20-100\xa0 IHC-P=1:100-500\xa0 IHC-F=1:100-500\xa0 IF=1:100-500\xa0
\t\t\t
\t\t\t抗体的生物素化标记：
\t\t\t（一）基本原理
\t\t\t本法可使抗体或其它蛋白质的e-氨基通过手臂与酰化的生物素共价结合。其后,生物素化的分子可应用酶标-亲和素或荧光染料-链霉亲和素复合物来检测。
\t\t\t（二）实验前准备
\t\t\t1.仪器设备
\t\t\t微量移液器，铝铂，透析袋(MWCO8000)，电磁搅拌器，分子筛柱。
\t\t\t2.试剂
\t\t\tNHSB:N-羟基琥珀酰亚胺生物素，0.1 mol/L碳酸氢钠缓冲液，双蒸水(注意去除游离氨基),用以配制碳酸氢钠缓冲液或硼酸缓冲液DMS0，10g/L牛血清白蛋白(W/W)PBS液等
\t\t\t（三）结果判定
\t\t\t与酶-或荧光染料-结合的亲和素、链霉亲和素或中和亲和素( neutravidin),通过标准方法（Westerblotting或免疫荧光染色法）测定交联率
\t\t\t产品应用\xa0\xa0 WB=1:100-500\xa0 ELISA=1:500-1000\xa0 IP=1:20-100\xa0 IHC-P=1:100-500\xa0 IHC-F=1:100-500\xa0 IF=1:100-500\xa0
\t\t\t
\t\t\t抗体的生物素化标记：
\t\t\t（一）基本原理
\t\t\t本法可使抗体或其它蛋白质的e-氨基通过手臂与酰化的生物素共价结合。其后,生物素化的分子可应用酶标-亲和素或荧光染料-链霉亲和素复合物来检测。
\t\t\t（二）实验前准备
\t\t\t1.仪器设备
\t\t\t微量移液器，铝铂，透析袋(MWCO8000)，电磁搅拌器，分子筛柱。
\t\t\t2.试剂
\t\t\tNHSB:N-羟基琥珀酰亚胺生物素，0.1 mol/L碳酸氢钠缓冲液，双蒸水(注意去除游离氨基),用以配制碳酸氢钠缓冲液或硼酸缓冲液DMS0，10g/L牛血清白蛋白(W/W)PBS液等
\t\t\t（三）结果判定
\t\t\t与酶-或荧光染料-结合的亲和素、链霉亲和素或中和亲和素( neutravidin),通过标准方法（Westerblotting或免疫荧光染色法）测定交联率
\t\t\t产品应用\xa0\xa0 WB=1:100-500\xa0 ELISA=1:500-1000\xa0 IP=1:20-100\xa0 IHC-P=1:100-500\xa0 IHC-F=1:100-500\xa0 IF=1:100-500\xa0
\t\t\t
\t\t\t抗体的生物素化标记：
\t\t\t（一）基本原理
\t\t\t本法可使抗体或其它蛋白质的e-氨基通过手臂与酰化的生物素共价结合。其后,生物素化的分子可应用酶标-亲和素或荧光染料-链霉亲和素复合物来检测。
\t\t\t（二）实验前准备
\t\t\t1.仪器设备
\t\t\t微量移液器，铝铂，透析袋(MWCO8000)，电磁搅拌器，分子筛柱。
\t\t\t2.试剂
\t\t\tNHSB:N-羟基琥珀酰亚胺生物素，0.1 mol/L碳酸氢钠缓冲液，双蒸水(注意去除游离氨基),用以配制碳酸氢钠缓冲液或硼酸缓冲液DMS0，10g/L牛血清白蛋白(W/W)PBS液等
\t\t\t（三）结果判定
\t\t\t与酶-或荧光染料-结合的亲和素、链霉亲和素或中和亲和素( neutravidin),通过标准方法（Westerblotting或免疫荧光染色法）测定交联率
\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t

solute carrier family 1\xa0\xa0溶质携带物家族-1(抗原)

SLC6A4 (solute carrier family 6)\xa0\xa0钾依赖钠钙交换蛋白6(抗原)

Survivin\xa0\xa0细胞凋亡抑制因子的一种（抗原）

BIYT5/Survivin variant\xa0\xa0细胞凋亡抑制因子4（抗原）

SSA/RO (ribonucleoprotein complex,RNP)\xa0\xa0核糖核蛋白抗原SSA(抗原)

SSB/La(Sjogren syndrome type B antigen)(抗原)\xa0\xa0抗干燥症SSB/La蛋白抗体

Smad2(Mothers against decapentaplegic homolog 2)\xa0\xa0Smad 2/3(抗原)

SPAG5/map126 (sperm associated antigen 5）\xa0\xa0抗精子相关抗原5(抗原)

SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)

SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)

SYVN1(synovial apoptosis inhibitor 1)\xa0\xa0滑膜细胞凋亡抑制物1（抗体）

SYK (Spleen tyrosine kinase)\xa0\xa0非受体型酪氨酸激酶(抗原)

\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tsolute carrier family 1\xa0\xa0溶质携带物家族-1(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSLC6A4 (solute carrier family 6)\xa0\xa0钾依赖钠钙交换蛋白6(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSurvivin\xa0\xa0细胞凋亡抑制因子的一种（抗原）\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tBIYT5/Survivin variant\xa0\xa0细胞凋亡抑制因子4（抗原）\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSSA/RO (ribonucleoprotein complex,RNP)\xa0\xa0核糖核蛋白抗原SSA(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSSB/La(Sjogren syndrome type B antigen)(抗原)\xa0\xa0抗干燥症SSB/La蛋白抗体\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSmad2(Mothers against decapentaplegic homolog 2)\xa0\xa0Smad 2/3(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSPAG5/map126 (sperm associated antigen 5）\xa0\xa0抗精子相关抗原5(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSYVN1(synovial apoptosis inhibitor 1)\xa0\xa0滑膜细胞凋亡抑制物1（抗体）\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSYK (Spleen tyrosine kinase)\xa0\xa0非受体型酪氨酸激酶(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tsolute carrier family 1\xa0\xa0溶质携带物家族-1(抗原)\t\t\t\t\t\t\t\t\t\t\tsolute carrier family 1\xa0\xa0溶质携带物家族-1(抗原)solute carrier family 1\xa0\xa0溶质携带物家族-1(抗原)solute carrier family 1\xa0\xa0溶质携带物家族-1(抗原)solute carrier family 1\xa0\xa0溶质携带物家族-1(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSLC6A4 (solute carrier family 6)\xa0\xa0钾依赖钠钙交换蛋白6(抗原)\t\t\t\t\t\t\t\t\t\t\tSLC6A4 (solute carrier family 6)\xa0\xa0钾依赖钠钙交换蛋白6(抗原)SLC6A4 (solute carrier family 6)\xa0\xa0钾依赖钠钙交换蛋白6(抗原)SLC6A4 (solute carrier family 6)\xa0\xa0钾依赖钠钙交换蛋白6(抗原)SLC6A4 (solute carrier family 6)\xa0\xa0钾依赖钠钙交换蛋白6(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSurvivin\xa0\xa0细胞凋亡抑制因子的一种（抗原）\t\t\t\t\t\t\t\t\t\t\tSurvivin\xa0\xa0细胞凋亡抑制因子的一种（抗原）Survivin\xa0\xa0细胞凋亡抑制因子的一种（抗原）Survivin\xa0\xa0细胞凋亡抑制因子的一种（抗原）Survivin\xa0\xa0细胞凋亡抑制因子的一种（抗原）\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tBIYT5/Survivin variant\xa0\xa0细胞凋亡抑制因子4（抗原）\t\t\t\t\t\t\t\t\t\t\tBIYT5/Survivin variant\xa0\xa0细胞凋亡抑制因子4（抗原）BIYT5/Survivin variant\xa0\xa0细胞凋亡抑制因子4（抗原）BIYT5/Survivin variant\xa0\xa0细胞凋亡抑制因子4（抗原）BIYT5/Survivin variant\xa0\xa0细胞凋亡抑制因子4（抗原）\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSSA/RO (ribonucleoprotein complex,RNP)\xa0\xa0核糖核蛋白抗原SSA(抗原)\t\t\t\t\t\t\t\t\t\t\tSSA/RO (ribonucleoprotein complex,RNP)\xa0\xa0核糖核蛋白抗原SSA(抗原)SSA/RO (ribonucleoprotein complex,RNP)\xa0\xa0核糖核蛋白抗原SSA(抗原)SSA/RO (ribonucleoprotein complex,RNP)\xa0\xa0核糖核蛋白抗原SSA(抗原)SSA/RO (ribonucleoprotein complex,RNP)\xa0\xa0核糖核蛋白抗原SSA(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSSB/La(Sjogren syndrome type B antigen)(抗原)\xa0\xa0抗干燥症SSB/La蛋白抗体\t\t\t\t\t\t\t\t\t\t\tSSB/La(Sjogren syndrome type B antigen)(抗原)\xa0\xa0抗干燥症SSB/La蛋白抗体SSB/La(Sjogren syndrome type B antigen)(抗原)\xa0\xa0抗干燥症SSB/La蛋白抗体SSB/La(Sjogren syndrome type B antigen)(抗原)\xa0\xa0抗干燥症SSB/La蛋白抗体SSB/La(Sjogren syndrome type B antigen)(抗原)\xa0\xa0抗干燥症SSB/La蛋白抗体\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSmad2(Mothers against decapentaplegic homolog 2)\xa0\xa0Smad 2/3(抗原)\t\t\t\t\t\t\t\t\t\t\tSmad2(Mothers against decapentaplegic homolog 2)\xa0\xa0Smad 2/3(抗原)Smad2(Mothers against decapentaplegic homolog 2)\xa0\xa0Smad 2/3(抗原)Smad2(Mothers against decapentaplegic homolog 2)\xa0\xa0Smad 2/3(抗原)Smad2(Mothers against decapentaplegic homolog 2)\xa0\xa0Smad 2/3(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSPAG5/map126 (sperm associated antigen 5）\xa0\xa0抗精子相关抗原5(抗原)\t\t\t\t\t\t\t\t\t\t\tSPAG5/map126 (sperm associated antigen 5）\xa0\xa0抗精子相关抗原5(抗原)SPAG5/map126 (sperm associated antigen 5）\xa0\xa0抗精子相关抗原5(抗原)SPAG5/map126 (sperm associated antigen 5）\xa0\xa0抗精子相关抗原5(抗原)SPAG5/map126 (sperm associated antigen 5）\xa0\xa0抗精子相关抗原5(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)\t\t\t\t\t\t\t\t\t\t\tSP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)\t\t\t\t\t\t\t\t\t\t\tSP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)SP-A (pulmonary surfactant-associated glycoprotein A)\xa0\xa0肺表面活性蛋白A(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSYVN1(synovial apoptosis inhibitor 1)\xa0\xa0滑膜细胞凋亡抑制物1（抗体）\t\t\t\t\t\t\t\t\t\t\tSYVN1(synovial apoptosis inhibitor 1)\xa0\xa0滑膜细胞凋亡抑制物1（抗体）SYVN1(synovial apoptosis inhibitor 1)\xa0\xa0滑膜细胞凋亡抑制物1（抗体）SYVN1(synovial apoptosis inhibitor 1)\xa0\xa0滑膜细胞凋亡抑制物1（抗体）SYVN1(synovial apoptosis inhibitor 1)\xa0\xa0滑膜细胞凋亡抑制物1（抗体）\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tSYK (Spleen tyrosine kinase)\xa0\xa0非受体型酪氨酸激酶(抗原)\t\t\t\t\t\t\t\t\t\t\tSYK (Spleen tyrosine kinase)\xa0\xa0非受体型酪氨酸激酶(抗原)SYK (Spleen tyrosine kinase)\xa0\xa0非受体型酪氨酸激酶(抗原)SYK (Spleen tyrosine kinase)\xa0\xa0非受体型酪氨酸激酶(抗原)SYK (Spleen tyrosine kinase)\xa0\xa0非受体型酪氨酸激酶(抗原)\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t